Mechanistic Role of the Calcium-Dependent Protease Calpain in the Endothelial Dysfunction Induced by MPO (Myeloperoxidase)

Abstract

MPO (myeloperoxidase) is a peroxidase enzyme secreted by activated leukocytes that plays a pathogenic role in cardiovascular disease, mainly by initiating endothelial dysfunction. The molecular mechanisms of the endothelial damaging action of MPO remain though largely elusive. Calpain is a calcium-dependent protease expressed in the vascular wall. Activation of calpains has been implicated in inflammatory disorders of the vasculature. Using endothelial cells and genetically modified mice, this study identifies the µ-calpain isoform as novel downstream signaling target of MPO in endothelial dysfunction. Mouse lung microvascular endothelial cells were stimulated with 10 nmol/L MPO for 180 minutes. MPO denitrosylated µ-calpain C-terminus domain, and time dependently activated µ-calpain, but not the m-calpain isoform. MPO also reduced Thr AMPK (AMP-activated protein kinase) and Ser eNOS (endothelial nitric oxide synthase) phosphorylation via upregulation of PP2A (protein phosphatase 2) expression. At the functional level, MPO increased endothelial VCAM-1 (vascular cell adhesion molecule 1) abundance and the adhesion of leukocytes to the mouse aorta. In MPO-treated endothelial cells, pharmacological inhibition of calpain activity attenuated expression of VCAM-1 and PP2A, and restored Thr AMPK and Ser eNOS phosphorylation. Compared with wild-type mice, µ-calpain deficient mice experienced reduced leukocyte adhesion to the aortic endothelium in response to MPO. Our data first establish a role for calpain in the endothelial dysfunction and vascular inflammation of MPO. The MPO/calpain/PP2A signaling pathway may provide novel pharmacological targets for the treatment of inflammatory vascular disorders.

SARS-CoV-2 Spike triggers barrier dysfunction and vascular leak via integrins and TGF-β signaling

“…Further, the DEGs obtained from HPMEC and HPMEC/ACE2 were similar, indicating ACE2 expression has minimal impact on the HPMEC transcriptional response to S. (Figures 5A, 5B, S4A, and S4B, Table S1, and S2). We observed numerous genes encoding ECM components, including proteoglycans, collagens and integrins, as well as genes coding for proteins involved in ECM degradation, such as CAPN2 (calpain), an endothelial cysteine protease, and HTRA1, which is responsible for degradation of fibronectin and proteoglycans, in agreement with our observations that S disrupts the EGL (46). Upregulation of XYLT2 (xylosyltransferase 2), an enzyme responsible for biosynthesis of CS, HS, and dermatan sulfate proteoglycans, is potentially involved in an EGL recovery pathway, post-S-mediated barrier dysfunction.…”

Dietary salt promotes cognitive impairment through tau phosphorylation

“…Calpain, once activated by Ca 2+ , is regulated mainly by its endogenous inhibitor calpastatin and by nitrosylation by NO 28 , which suppress its activity 29 . Since HSD did not reduce calpastatin expression (Extended Data Fig.…”

Angiotensin II Decreases Endothelial Nitric Oxide Synthase Phosphorylation via AT1R Nox/ROS/PP2A Pathway

“…It is composed of structural subunit A, regulatory subunit B, and catalytic subunit C. PP2A regulates several important cellular processes, such as cell cycle, apoptosis, cell metabolism, and migration, via dephosphorylation of intracellular proteins ( Apostolidis et al, 2016 ; Wlodarchak and Xing, 2016 ). Studies have shown that PP2A is activated in CVD, and that activated PP2A could lead to ED via dephosphorylation of eNOS or Akt ( Zhang et al, 2012 ; Etwebi et al, 2018 ; Schnelle et al, 2019 ). AngII/AT 1 R can enhance the activity of PP2A in cardiomyocytes ( Everett et al, 2001 ) as well as HUVECs ( Luo et al, 2019 ).…”